Skip to content

Investigator

Kurt Derek Christensen

HARVARD PILGRIM HEALTH CARE, INC. · funded by NICHD

Companies
3

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$2.8M

Summed across those awards.

First award
Sep 11, 2017

Latest Sep 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Long-term Impact and Value of Infant Genomic Sequencing (LIVING)

    $714k

    Sep 1, 2024NICHDHARVARD PILGRIM HEALTH CARE, INC.NIH RePORTER · 11176797 (opens the source filing in a new tab)

  2. R01

    Long-term Impact and Value of Infant Genomic Sequencing (LIVING)

    $705k

    Sep 1, 2024NICHDHARVARD PILGRIM HEALTH CARE, INC.NIH RePORTER · 11336311 (opens the source filing in a new tab)

  3. R01

    Precision Medicine Policy and Treatment (PreEMPT) Model II

    $686k

    Sep 11, 2017NICHDHARVARD PILGRIM HEALTH CARE, INC.NIH RePORTER · 11040323 (opens the source filing in a new tab)

  4. R01

    Precision Medicine Policy and Treatment (PreEMPT) Model II

    $672k

    Sep 11, 2017NICHDHARVARD PILGRIM HEALTH CARE, INC.NIH RePORTER · 11285269 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources